VJHemOnc is committed to improving our service to you

MDS 2020 | Optimizing transplantation for MDS

VJHemOnc is committed to improving our service to you

Theo de Witte

Theo de Witte, MD, Radboud University Medical Center, Nijmegen, The Netherlands, discusses stem cell transplantation for the treatment of myelodysplastic syndromes (MDS) and how we can optimize outcomes when using this option. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter